Method for the treatment of multiple sclerosis
CA 2844639 A1 · Owner: The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services · Inventors: Martin, Roland; Bielekova, Bibiana; Mcfarland, Henry F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating a subject with multiple sclerosis is disclosed herein. In one , embodiment, a method is provided for treating a subject with multiple sclerosis that includes , administering to the subject a therapeutically effective amount of an IL-21 receptor , antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby , treating the subject.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 27, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.